These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 30215558

  • 1. Growth hormone and prolactin-staining tumors causing acromegaly: a retrospective review of clinical presentations and surgical outcomes.
    Rick J, Jahangiri A, Flanigan PM, Chandra A, Kunwar S, Blevins L, Aghi MK.
    J Neurosurg; 2019 Jul 01; 131(1):147-153. PubMed ID: 30215558
    [Abstract] [Full Text] [Related]

  • 2. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
    Tamanini JVG, Dal Fabbro M, de Freitas LLL, Vassallo J, de Souza Queiroz L, Rogerio F.
    Neurosurg Focus; 2020 Jun 01; 48(6):E12. PubMed ID: 32480373
    [Abstract] [Full Text] [Related]

  • 3. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G.
    Neurosurg Focus; 2020 Jun 01; 48(6):E10. PubMed ID: 32480366
    [Abstract] [Full Text] [Related]

  • 4. Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.
    Petrossians P, Borges-Martins L, Espinoza C, Daly A, Betea D, Valdes-Socin H, Stevenaert A, Chanson P, Beckers A.
    Eur J Endocrinol; 2005 Jan 01; 152(1):61-6. PubMed ID: 15762188
    [Abstract] [Full Text] [Related]

  • 5. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature.
    Almeida JP, Ruiz-Treviño AS, Liang B, Omay SB, Shetty SR, Chen YN, Anand VK, Grover K, Christos P, Schwartz TH.
    J Neurosurg; 2018 Aug 01; 129(2):404-416. PubMed ID: 28862548
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
    J Neurosurg; 2014 Dec 01; 121(6):1462-73. PubMed ID: 25237847
    [Abstract] [Full Text] [Related]

  • 7. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly.
    Nyquist P, Laws ER, Elliott E.
    Neurosurgery; 1994 Aug 01; 35(2):179-83; discussion 183-4. PubMed ID: 7969823
    [Abstract] [Full Text] [Related]

  • 8. Diagnosis and treatment of pituitary adenomas.
    Chanson P, Salenave S.
    Minerva Endocrinol; 2004 Dec 01; 29(4):241-75. PubMed ID: 15765032
    [Abstract] [Full Text] [Related]

  • 9. Surgical Management of Carney Complex-Associated Pituitary Pathology.
    Lonser RR, Mehta GU, Kindzelski BA, Ray-Chaudhury A, Vortmeyer AO, Dickerman R, Oldfield EH.
    Neurosurgery; 2017 May 01; 80(5):780-786. PubMed ID: 27509071
    [Abstract] [Full Text] [Related]

  • 10. Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly.
    Cardinal T, Collet C, Wedemeyer M, Singer PA, Weiss M, Zada G, Carmichael JD.
    Front Endocrinol (Lausanne); 2021 May 01; 12():743052. PubMed ID: 34867787
    [Abstract] [Full Text] [Related]

  • 11. 2010 versus the 2000 consensus criteria in patients with normalised insulin-like growth factor 1 after transsphenoidal surgery has high predictive values for long-term recurrence-free survival in acromegaly.
    Shen M, Chen Z, Shou X, He W, Qiao N, Ma Z, Ye Z, Zhang Y, Zhang Q, Zhou X, Cao X, Zhang Z, Ye H, Li Y, Zhao Y, Li S, He M, Wang Y.
    J Neuroendocrinol; 2021 May 01; 33(5):e12958. PubMed ID: 33998086
    [Abstract] [Full Text] [Related]

  • 12. Cystic appearance on magnetic resonance imaging in bihormonal growth hormone and prolactin tumors in acromegaly.
    Varlamov EV, Wood MD, Netto JP, Thiessen J, Kim J, Lim DST, Yedinak CG, Banskota S, Cetas JS, Fleseriu M.
    Pituitary; 2020 Dec 01; 23(6):672-680. PubMed ID: 32870441
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
    Kreutzer J, Vance ML, Lopes MB, Laws ER.
    J Clin Endocrinol Metab; 2001 Sep 01; 86(9):4072-7. PubMed ID: 11549628
    [Abstract] [Full Text] [Related]

  • 15. A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin.
    De Marinis L, Zuppi P, Valle D, Mancini A, Bianchi A, Lauriola L, Pasquini P, Anile C, Maira G, Giustina A.
    Horm Metab Res; 2002 Mar 01; 34(3):137-43. PubMed ID: 11972303
    [Abstract] [Full Text] [Related]

  • 16. Pituitary surgery for the management of acromegaly.
    Laws ER, Vance ML, Thapar K.
    Horm Res; 2000 Mar 01; 53 Suppl 3():71-5. PubMed ID: 10971109
    [Abstract] [Full Text] [Related]

  • 17. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
    Colao A, Attanasio R, Pivonello R, Cappabianca P, Cavallo LM, Lasio G, Lodrini A, Lombardi G, Cozzi R.
    J Clin Endocrinol Metab; 2006 Jan 01; 91(1):85-92. PubMed ID: 16263832
    [Abstract] [Full Text] [Related]

  • 18. Long-Term Effects of Intracapsular Debulking and Adjuvant Somatostatin Analogs for Growth Hormone-Secreting Pituitary Macroadenoma: 10 Years of Experience in a Single Institute.
    Shen SC, Shen CC, Pu TW, Cheng WY.
    World Neurosurg; 2019 Jun 01; 126():e41-e47. PubMed ID: 30716503
    [Abstract] [Full Text] [Related]

  • 19. In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells.
    Cuny T, Zeiller C, Bidlingmaier M, Défilles C, Roche C, Blanchard MP, Theodoropoulou M, Graillon T, Pertuit M, Figarella-Branger D, Enjalbert A, Brue T, Barlier A.
    Endocr Relat Cancer; 2016 Jul 01; 23(7):509-19. PubMed ID: 27267119
    [Abstract] [Full Text] [Related]

  • 20. Cabergoline therapy of growth hormone & growth hormone/prolactin secreting pituitary tumors.
    Freda PU, Reyes CM, Nuruzzaman AT, Sundeen RE, Khandji AG, Post KD.
    Pituitary; 2004 Jul 01; 7(1):21-30. PubMed ID: 15638294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.